Objective: Accurate diagnosis and prognosis are essential in lung cancer treatment
selection and planning. With the rapid advance of medical imaging technology, whole slide …

Abstract The 2015 World Health Organization (WHO) Classification of Tumors of the Lung,
Pleura, Thymus and Heart has just been published with numerous important changes from …

Introduction A grading system for pulmonary adenocarcinoma has not been established.
The International Association for the Study of Lung Cancer pathology panel evaluated a set …

Lung cancer is the leading cause of cancer mortality worldwide with 1.8 million newly
diagnosed cases, or 13% of all cancers diagnosed, in 2012 [1]. The worldwide numbers are …

Lung cancer is the most prevalent cancer worldwide, and histopathological assessment is
indispensable for its diagnosis. However, human evaluation of pathology slides cannot …

Classification of histologic patterns in lung adenocarcinoma is critical for determining tumor
grade and treatment for patients. However, this task is often challenging due to the …

Purpose The survival benefit with adjuvant chemotherapy for patients with resected stage II-
III non–small-cell lung cancer (NSCLC) is modest. Efforts to develop prognostic or predictive …

Purpose The panel updated the American Society of Clinical Oncology (ASCO) adjuvant
therapy guideline for resected non–small-cell lung cancers. Methods ASCO convened an …

High‐throughput and streamlined workflows are essential in clinical proteomics for
standardized processing of samples from a variety of sources, including fresh‐frozen tissue …

Lung cancer continues to be a major global health problem; the disease is diagnosed in
more than 1.6 million new patients each year. However, significant progress is underway in …